Discover how UBX-306, a novel HPK1 degrader using PROTAC technology, is revolutionizing cancer immunotherapy by eliminating immune system brakes at the molecular level.
Discover how inhibiting SUMOylation with TAK-981 reprograms immune defenses and transforms cancer treatment by awakening macrophage and NK cell functions.